• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肺癌调强放射治疗计划的预后引导优化]

[Prognosis-guided optimization of intensity-modulated radiation therapy plans for lung cancer].

作者信息

Li Huali, Song Ting, Liu Jiawen, Li Yongbao, Jiang Zhaojing, Dou Wen, Zhou Linghong

机构信息

Department of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.

State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2025 Mar 20;45(3):643-649. doi: 10.12122/j.issn.1673-4254.2025.03.22.

DOI:10.12122/j.issn.1673-4254.2025.03.22
PMID:40159979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11955899/
Abstract

OBJECTIVES

To propose a new method for optimizing radiotherapy planning for lung cancer by incorporating prognostic models that take into account individual patient information and assess the feasibility of treatment planning optimization directly guided by minimizing the predicted prognostic risk.

METHODS

A mixed fluence map optimization objective was constructed, incorporating the outcome-based objective and the physical dose constraints. The outcome-based objective function was constructed as an equally weighted summation of prognostic prediction models for local control failure, radiation-induced cardiac toxicity, and radiation pneumonitis considering clinical risk factors. These models were derived using Cox regression analysis or Logistic regression. The primary goal was to minimize the outcome-based objective with the physical dose constraints recommended by the clinical guidelines. The efficacy of the proposed method for optimizing treatment plans was tested in 15 cases of non-small cell lung cancer in comparison with the conventional dose-based optimization method (clinical plan), and the dosimetric indicators and predicted prognostic outcomes were compared between different plans.

RESULTS

In terms of the dosemetric indicators, D of the planning target volume obtained using the proposed method was basically consistent with that of the clinical plan (100.33% 102.57%, =0.056), and the average dose of the heart and lungs was significantly decreased from 9.83 Gy and 9.50 Gy to 7.02 Gy (=4.537, 0.05) and 8.40 Gy (=4.104, 0.05), respectively. The predicted probability of local control failure was similar between the proposed plan and the clinical plan (60.05% 59.66%), while the probability of radiation-induced cardiac toxicity was reduced by 1.41% in the proposed plan.

CONCLUSIONS

The proposed optimization method based on a mixed objective function of outcome prediction and physical dose provides effective protection against normal tissue exposure to improve the outcomes of lung cancer patients following radiotherapy.

摘要

目的

提出一种新的方法,通过纳入考虑个体患者信息的预后模型来优化肺癌放疗计划,并评估在最小化预测的预后风险直接指导下进行治疗计划优化的可行性。

方法

构建了一个混合通量图优化目标,纳入基于结果的目标和物理剂量约束。基于结果的目标函数构建为考虑临床风险因素的局部控制失败、放射性心脏毒性和放射性肺炎预后预测模型的等加权总和。这些模型通过Cox回归分析或Logistic回归得出。主要目标是在临床指南推荐的物理剂量约束下最小化基于结果的目标。与传统的基于剂量的优化方法(临床计划)相比,在所提出的方法在15例非小细胞肺癌中测试了优化治疗计划的效果,并比较了不同计划之间的剂量学指标和预测的预后结果。

结果

在剂量学指标方面,使用所提出方法获得的计划靶体积的D与临床计划基本一致(100.33% 102.57%, =0.056),心脏和肺的平均剂量分别从9.83 Gy和9.50 Gy显著降低至7.02 Gy( =4.537, 0.05)和8.40 Gy( =4.104, 0.05)。所提出的计划与临床计划之间局部控制失败的预测概率相似(60.05% 59.66%),而所提出的计划中放射性心脏毒性的概率降低了1.41%。

结论

所提出的基于结果预测和物理剂量混合目标函数的优化方法为正常组织暴露提供了有效的保护,以改善肺癌患者放疗后的预后。

相似文献

1
[Prognosis-guided optimization of intensity-modulated radiation therapy plans for lung cancer].[肺癌调强放射治疗计划的预后引导优化]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Mar 20;45(3):643-649. doi: 10.12122/j.issn.1673-4254.2025.03.22.
2
Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization.直接将患者特异性疗效和毒性估计纳入放射治疗计划优化。
Med Phys. 2022 Oct;49(10):6279-6292. doi: 10.1002/mp.15940. Epub 2022 Sep 2.
3
Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.早期非小细胞肺癌患者立体定向体部放疗计划的稳健优化
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820916505. doi: 10.1177/1533033820916505.
4
Embedding machine learning based toxicity models within radiotherapy treatment plan optimization.将基于机器学习的毒性模型嵌入放射治疗计划优化中。
Phys Med Biol. 2024 Mar 14;69(7). doi: 10.1088/1361-6560/ad2d7e.
5
Individualized estimates of overall survival in radiation therapy plan optimization - A concept study.个体化估计放射治疗计划优化中的总生存期——概念研究。
Med Phys. 2018 Nov;45(11):5332-5342. doi: 10.1002/mp.13211. Epub 2018 Oct 17.
6
Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.调强放射治疗作为一种补充治疗对非小细胞肺癌肺部剂量分布的影响。
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):683-9. doi: 10.1016/j.ijrobp.2005.03.012. Epub 2005 May 31.
7
Impact of dose calculation accuracy during optimization on lung IMRT plan quality.优化过程中剂量计算准确性对肺部调强放疗计划质量的影响。
J Appl Clin Med Phys. 2015 Jan 8;16(1):5137. doi: 10.1120/jacmp.v16i1.5137.
8
Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.实时MRI引导的三钴-60与基于直线加速器的立体定向体部放射治疗肺癌计划的剂量学比较
Technol Cancer Res Treat. 2017 Jun;16(3):366-372. doi: 10.1177/1533034617691407. Epub 2017 Feb 7.
9
Regression models for predicting physical and EQD plan parameters of two methods of hybrid planning for stage III NSCLC.用于预测 III 期 NSCLC 两种混合计划方法的物理和 EQD 计划参数的回归模型。
Radiat Oncol. 2021 Jun 27;16(1):119. doi: 10.1186/s13014-021-01848-9.
10
Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.基于放射生物学指标的螺旋断层放射治疗与基于多叶准直器的调强放射治疗的治疗计划比较
Phys Med Biol. 2007 Jul 7;52(13):3817-36. doi: 10.1088/0031-9155/52/13/011. Epub 2007 May 31.

本文引用的文献

1
Factors associated with acute esophagitis during radiation therapy for lung cancer.与肺癌放射治疗期间急性食管炎相关的因素。
Radiother Oncol. 2024 Aug;197:110349. doi: 10.1016/j.radonc.2024.110349. Epub 2024 May 28.
2
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].《中国医学协会肺癌临床诊疗指南(2023年版)》
Zhonghua Yi Xue Za Zhi. 2023 Jul 18;103(27):2037-2074. doi: 10.3760/cma.j.cn112137-20230510-00767.
3
Automatic Radiobiological Comparison of Radiation Therapy Plans: An Application to Gastric Cancer.放射治疗计划的自动放射生物学比较:在胃癌中的应用
Cancers (Basel). 2022 Dec 11;14(24):6098. doi: 10.3390/cancers14246098.
4
Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium.呼吸和心血管合并症与 I 期至 III 期 NSCLC 生存:国际肺癌联合会的汇总分析。
J Thorac Oncol. 2023 Mar;18(3):313-323. doi: 10.1016/j.jtho.2022.10.020. Epub 2022 Nov 15.
5
Artificial Intelligence for Outcome Modeling in Radiotherapy.用于放射治疗结果建模的人工智能
Semin Radiat Oncol. 2022 Oct;32(4):351-364. doi: 10.1016/j.semradonc.2022.06.005.
6
Current status and future developments in predicting outcomes in radiation oncology.放射肿瘤学中预测结果的现状和未来发展。
Br J Radiol. 2022 Oct 1;95(1139):20220239. doi: 10.1259/bjr.20220239. Epub 2022 Jul 28.
7
Personalised radiation therapy taking both the tumour and patient into consideration.兼顾肿瘤和患者情况的个性化放射治疗。
Radiother Oncol. 2022 Jan;166:A1-A5. doi: 10.1016/j.radonc.2022.01.010. Epub 2022 Jan 17.
8
Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification.辐射诱发心脏毒性的过去、现在与未来:靶向治疗、监测及风险分层的优化
JACC CardioOncol. 2021 Sep 21;3(3):343-359. doi: 10.1016/j.jaccao.2021.06.007. eCollection 2021 Sep.
9
Outcome-based multiobjective optimization of lymphoma radiation therapy plans.基于结果的淋巴瘤放射治疗计划的多目标优化。
Br J Radiol. 2021 Nov 1;94(1127):20210303. doi: 10.1259/bjr.20210303. Epub 2021 Sep 30.
10
Radiation-induced lung injury: current evidence.放射性肺损伤:当前证据。
BMC Pulm Med. 2021 Jan 6;21(1):9. doi: 10.1186/s12890-020-01376-4.